CYTK icon

Cytokinetics
CYTK

Overview Fund Activity

352 hedge funds and large institutions have $5.53B invested in Cytokinetics in 2025 Q1 according to their latest regulatory filings, with 56 funds opening new positions, 139 increasing their positions, 109 reducing their positions, and 44 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
352
Holders Change
+9
Holders Change %
+2.62%
% of All Funds
4.78%
Holding in Top 10
12
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-20%
% of All Funds
0.16%
New
56
Increased
139
Reduced
109
Closed
44
Calls
$184M
Puts
$45.7M
Net Calls
+$138M
Net Calls Change
+$58.6M

Top Buyers

1
Bank of America
Bank of America
North Carolina
$109M
2
Point72 Asset Management
Point72 Asset Management
Connecticut
$69.2M
3
UBS Group
UBS Group
Switzerland
$85.8M
4
PBA
Paradigm Biocapital Advisors
New York
$34.5M
5
Jennison Associates
Jennison Associates
New York
$27.1M

Top Sellers

1
LGM
Logos Global Management
California
$0
2
PCM
Pentwater Capital Management
Florida
$8.84M
3
T. Rowe Price Investment Management
T. Rowe Price Investment Management
Maryland
$400M
4
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
$80.1M
5
Fidelity Investments
Fidelity Investments
Massachusetts
$415M
Name Holding Trade Value Shares
Change 		Shares
Change %
HRCM
26
Hood River Capital Management
Florida
$50.5M +$10.7M +267,332 +27%
Capital International Investors
27
Capital International Investors
California
$46.9M +$2.89M +71,946 +7%
Citadel Advisors
28
Citadel Advisors
Florida
$46.2M -$8.89M -221,131 -16%
Janus Henderson Group
29
Janus Henderson Group
United Kingdom
$45.7M +$1.41M +32,729 +3%
IHAM
30
Integral Health Asset Management
New York
$44.2M +$4.02M +100,000 +10%
Brown Advisory
31
Brown Advisory
Maryland
$43.7M +$397K +9,869 +0.9%
AC
32
Armistice Capital
New York
$41.1M -$11.6M -288,610 -22%
Morgan Stanley
33
Morgan Stanley
New York
$40.7M -$9.7M -241,243 -19%
MAM
34
Melqart Asset Management
United Kingdom
$40.2M -$5.51M -136,987 -12%
RM
35
RP Management
New York
$39.4M – – –
Bank of New York Mellon
36
Bank of New York Mellon
New York
$35M -$918K -22,830 -3%
PBA
37
Paradigm Biocapital Advisors
New York
$34.5M +$34.5M +858,664 New
Fisher Asset Management
38
Fisher Asset Management
Washington
$31.9M +$7.11M +176,966 +29%
Ameriprise
39
Ameriprise
Minnesota
$31.6M +$1.37M +34,182 +5%
Jane Street
40
Jane Street
New York
$30.4M +$26M +647,584 +599%
Jennison Associates
41
Jennison Associates
New York
$27.1M +$27.1M +673,932 New
Principal Financial Group
42
Principal Financial Group
Iowa
$25.3M +$14.4M +358,778 +132%
Aberdeen Group
43
Aberdeen Group
United Kingdom
$24.2M +$6.11M +151,908 +34%
SCM
44
Sarissa Capital Management
Connecticut
$24.1M -$9.4M -233,799 -28%
CCM
45
Catalio Capital Management
New York
$23.5M +$5.15M +128,225 +28%
Susquehanna International Group
46
Susquehanna International Group
Pennsylvania
$21.7M +$16.1M +399,993 +288%
Franklin Resources
47
Franklin Resources
California
$21.6M -$329K -8,189 -2%
BNP Paribas Asset Management
48
BNP Paribas Asset Management
France
$21M +$1.33M +33,106 +7%
Invesco
49
Invesco
Georgia
$20.2M -$638K -15,883 -3%
TD Asset Management
50
TD Asset Management
Ontario, Canada
$18M -$3.13M -77,806 -15%
1
2
3 4 5